The iShares U.S. Consumer Staples ETF (IYK) seeks to track the investment results of an index composed of U.S. equities in the consumer staples sector. Launched in 2000, the fund is non-diversified and structured as a passive index-tracking vehicle, generally investing at least 80% of its assets in the component securities of its underlying index. It manages roughly $1.4 billion in assets under management and carries an expense ratio of 0.38%.
The portfolio spans approximately 57 holdings concentrated in large-cap, dividend-paying names. Top positions include Procter & Gamble, Coca-Cola, Philip Morris International, PepsiCo, Altria Group, CVS Health, McKesson, Mondelez, Colgate-Palmolive, and Monster Beverage. Unlike many peers, the fund adds a healthcare allocation of roughly 13% and a small basic-materials position, which modestly reduces pure staples concentration. I also checked this using Tickeron’s AI Screener to see how the holdings compare to others in the industry.
Consumer staples occupy a defensive corner of the equity market, characterized by relatively inelastic demand for food, beverages, household products, and personal care goods. That structural characteristic tends to support more stable revenue streams through economic cycles and can make the sector a preferred destination when investors seek lower-volatility equity exposure.
The broader backdrop has favored defensives. Elevated interest rates and persistent cost pressures have kept a premium on companies with pricing power and predictable cash flows. Meanwhile, healthcare distribution names—such as McKesson and CVS Health, which sit within IYK's healthcare sleeve—add a counterweight tied to different demand drivers, including pharmaceutical volumes and healthcare spending. This blend means IYK's performance reflects not only consumer demand but also healthcare services and a modest materials component.
IYK has delivered a strong recent stretch. Over the trailing 30 days, the fund has risen approximately 9.8%, while its three-month advance is closer to 5%. The fund pulled back through late summer into early autumn, slipping toward the low $70s, before staging a sharp recovery that carried it back toward the upper end of its 52-week trading range, which spans roughly $65 to $78.
This rebound reflects a broader rotation into defensive and income-generating equities. Strength among the fund's largest holdings—particularly household products leader Procter & Gamble, beverage giant Coca-Cola, and tobacco firm Philip Morris International—has been a meaningful contributor, given their combined weight. A mid-teens year-to-date gain further illustrates the sector's leadership as investors have rewarded stable earnings, robust free cash flow, and consistent dividend growth amid macro uncertainty. From what I see, the low five-year beta near 0.5 and dividend yield around 2.5% continue to highlight its defensive profile.
Several structural themes are likely to shape IYK over the remainder of 2026. The trajectory of inflation and consumer purchasing power remains central, since persistent price increases can pressure volumes even for essential goods, while moderating input costs would support margins. Interest-rate expectations also matter: falling yields tend to enhance the appeal of dividend-paying staples relative to fixed income, whereas higher-for-longer rates could restrain valuation multiples.
The earnings cycles of major holdings—across beverages, tobacco, packaged food, and household products—will continue to drive index-level results. Healthcare distribution names add a second layer of sensitivity to pharmaceutical pricing and policy developments. Currency effects are another consideration for multinationals such as Coca-Cola, Philip Morris International, and Mondelez. Finally, capital flows into defensive and income-oriented ETFs, along with competition from lower-cost staples funds, may influence demand for the fund. These factors, rather than short-term price swings, are likely to define the fund's trajectory in the months ahead. I'm watching this closely as earnings reports roll in.
In my own analysis, I often turn to Tickeron’s AI-powered tools to cross-check sector trends and comparable holdings. The AI Screener lets me filter thousands of securities by technical indicators, fundamentals, volatility, and AI-generated signals, which helps surface ideas in defensive areas like consumer staples more efficiently than manual methods. It has become a regular part of how I evaluate exposure and compare opportunities at scale.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Moving Average Convergence Divergence (MACD) for IYK turned positive on October 07, 2026. Looking at past instances where IYK's MACD turned positive, the stock continued to rise in 38 of 44 cases over the following month. The odds of a continued upward trend are 86%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on IYK as a result. In 72 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.
IYK moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for IYK crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 78%.
Following a +2.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where IYK advanced for three days, in 265 of 336 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 232 of 299 cases where IYK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
The 10-day RSI Indicator for IYK moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In 32 of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at 82%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 48 of 61 cases where IYK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IYK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
IYK broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ConsumerStaples